Abdun-Nabi Daniel
SEC CIK 1380187 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APVO | Aptevo Therapeutics Inc. | Dir | 400 | — | — | 6 | 2022-06-01 | 2026-08-06 |
Most active insiders at APVO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grant Grady III | Dir | $20.1K | — |
| 2 | Kwon SoYoung | SVP, GC, BD, Corp Affairs | — | — |
| 3 | Huebner Dirk | SVP, CMO | — | — |
| 4 | Kunz Barbara Lopez | Dir | — | — |
| 5 | Lamothe Jeffrey G. | Pres, CEO, Dir | — | — |
| 6 | Niederhuber John | Dir | — | — |
| 7 | White Marvin L | Executive COB, Dir | — | — |
| 8 | Taylor Daphne | SVP, CFO | — | — |
| 9 | Abdun-Nabi Daniel | Dir | — | — |
| 10 | Harsanyi Zsolt | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 21:33 | 2026-08-06 | APVO | Aptevo Therapeutics Inc. | Abdun-Nabi Daniel | Dir | M - OptEx | — | +400 | 400 | New | — |
| D | 2025-07-21 | 2025-07-17 | APVO | Aptevo Therapeutics Inc. | Abdun-Nabi Daniel | Dir | M - OptEx | — | +1 | 1 | New | — |
| DM | 2024-06-03 | 2024-06-01+ | APVO | Aptevo Therapeutics Inc. | Abdun-Nabi Daniel | Dir | M - OptEx | — | +88 | 277 | +47% | — |
| D | 2023-08-10 | 2023-08-09 | APVO | Aptevo Therapeutics Inc. | Abdun-Nabi Daniel | Dir | M - OptEx | — | +3,571 | 8,339 | +75% | — |
| D | 2023-06-02 | 2023-06-01 | APVO | Aptevo Therapeutics Inc. | Abdun-Nabi Daniel | Dir | M - OptEx | — | +297 | 4,768 | +7% | — |
| D | 2022-06-03 | 2022-06-01 | APVO | Aptevo Therapeutics Inc. | Abdun-Nabi Daniel | Dir | M - OptEx | — | +298 | 8,108 | +4% | — |
Purchase Sale Sale after option exercise All abbreviations